Zolpidem is not superior to temazepam with respect to rebound insomnia: a controlled study.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  European Neuropsychopharmacology

• Publication date

  2004-08-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/J.EURONEURO.2003.09.007PMID 15163440
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rebound insomnia and newer hypnotics

  2005cited by this paper
• Effects of zolpidem 10 mg, zopiclone 7.5 mg and flunitrazepam 1 mg on night-time motor activity.

  2003cited by this paper
• Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia.

  2000cited by this paper
• Eight weeks of non-nightly use of zolpidem for primary insomnia.

  2000cited by this paper
• Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype

  2000cited by this paper
• Precipitated and spontaneous withdrawal following administration of lorazepam but not zolpidem.

  2000cited by this paper
• Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.

  1999cited by this paper
• New Insights Into The Mechanism of Action of Hypnotics

  1999cited by this paper
• General safety profile of zolpidem: safety in elderly, overdose and rebound effects

  1997cited by this paper
• Chronic zolpidem treatment alters GABA(A) receptor mRNA levels in the rat cortex.

  1997cited by this paper
• Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy.

  1997cited by this paper
• Minimal rebound insomnia after treatment with 10-mg zolpidem.

  1997cited by this paper
• Subjective Efficacy of Zolpidem in Outpatients with Chronic Insomnia

  1997cited by this paper
• Double‐blind, placebo‐controlled comparison of zolpidem, triazolam, and temazepam in elderly patients with insomnia

  1997cited by this paper
• Zolpidem, triazolam, and temazepam: behavioral and subject-rated effects in normal volunteers.

  1996cited by this paper
• Rebound insomnia after abrupt discontinuation of hypnotic treatment: double‐blind randomized comparison of zolpidem versus triazolam

  1996cited by this paper
• Sleep in patients with chronic primary insomnia during long‐term zolpidem administration and after its withdrawal

  1996cited by this paper
• A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.

  1994cited by this paper
• Basic and Clinical Biostatistics

  1993cited by this paper
• Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia.

  1993cited by this paper
• Pilot Controlled Double-Blind Study of the Hypnotic Effects of Zolpidem in Patients with Chronic ‘Learned’ Insomnia: Psychometric and Polysomnographic Evaluation

  1993cited by this paper
• Rebound insomnia after only brief and intermittent use of rapidly eliminated benzodiazepines

  1991cited by this paper
• Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation.

  1990cited by this paper
• Rebound Insomnia: A Critical Review

  1989cited by this paper
• Rebound insomnia and rebound anxiety: a review.

  1983cited by this paper

• A pilot, parallel-group, blinded, placebo-controlled, randomiseD, pRagmatic clinical trial investigating the Effect of temazepAM on objective and subjective measures of sleep in critically ill patients (the DREAM trial).

  2026cites this paper
• Commercial Chinese polyherbal preparation Zao Ren An Shen prescription for primary insomnia: a systematic review with meta-analysis and trial sequential analysis

  2024cites this paper
• Assessing the Risk of Bias in Randomized Clinical Trials With Large Language Models

  2024cites this paper
• Effects of tranquilization therapy in elderly patients suffering from chronic non-communicable diseases: A meta-analysis

  2023cites this paper
• Gender differences in spontaneous adverse event reports associated with zolpidem in South Korea, 2015–2019

  2023cites this paper
• The Comparative Effectiveness and Safety of Insomnia Drugs: A Systematic Review and Network Meta-Analysis of 153 Randomized Trials

  2023cites this paper
• Hypnotic Discontinuation in Chronic Insomnia.

  2022cites this paper
• Network meta-analysis comparing the effectiveness of a prescription digital therapeutic for chronic insomnia to medications and face-to-face cognitive behavioral therapy in adults

  2022cites this paper
• Dependence on hypnotics: a comparative study between chronic users of benzodiazepines and Z-drugs

  2021cites this paper
• Comparative efficacy of lemborexant and other insomnia treatments: a network meta-analysis

  2021cites this paper
• Contents

  2020cites this paper
• Hypnotic Discontinuation in Chronic Insomnia.

  2020cites this paper
• British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update

  2019cites this paper
• Dependence, withdrawal and rebound of CNS drugs: an update and regulatory considerations for new drugs development

  2019cites this paper
• Reintroduction of quazepam: an update on comparative hypnotic and adverse effects.

  2019cites this paper
• Hypnotic Discontinuation in Chronic Insomnia.

  2018cites this paper
• Zolpidem's use for insomnia.

  2017cites this paper
• Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline

  2017influential citation
• Pharmacologic Treatment of Insomnia Disorder: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians

  2016cites this paper
• Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults

  2016cites this paper
• The Effect of Melatonin on Benzodiazepine Discontinuation and Sleep Quality in Adults Attempting to Discontinue Benzodiazepines: A Systematic Review and Meta-Analysis

  2015cites this paper
• Insomnia and sleep apnea in midlife women: prevalence and consequences to health and functioning

  2015cites this paper
• Sleep and Sleep–Wake Disorders

  2015cites this paper
• Treatment of Insomnia, Insomnia Symptoms, and Obstructive Sleep Apnea During and After Menopause: Therapeutic Approaches.

  2015cites this paper
• Management of Insomnia Disorder

  2015cites this paper
• Hypnotics in insomnia: the experience of zolpidem.

  2014cites this paper
• Slaapproblemen en slaapmiddelen

  2014cites this paper
• Psychofarmaca bij de behandeling van slaapstoornissen

  2013cites this paper
• Psychofarmaca bij de behandeling van

  2013cites this paper
• Sleep and Women's Health.

  2013cites this paper
• A new sublingual formulation of zolpidem for the treatment of sleep-onset insomnia

  2012cites this paper
• circadian rhythm disorders British Association for Psychopharmacology consensus statement on evidence-based treatment of

  2010cites this paper
• British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders

  2010cites this paper
• Zolpidem in the Treatment of Adult and Elderly Primary Insomnia Patients

  2010cites this paper
• Insomnia in Patients with Depression

  2009cites this paper
• Pharmacotherapy of Insomnia: Focus on Zolpidem Extended Release

  2009cites this paper
• Schizophrenia Antipsychotics – general introduction

  2009cites this paper
• Drug Class Review: Nasal Corticosteroids

  2008cites this paper
• The ZZZs to success: A good night's sleep is more than beauty rest

  2008cites this paper
• Rebound insomnia induced by abrupt withdrawal of hypnotics in sleep-disturbed rats.

  2008cites this paper
• Drug Class Review Newer Drugs for Insomnia

  2008cites this paper
• Pharmacological Treatment of Insomnia

  2007cites this paper
• Sleep Disturbance in Supportive Care of Cancer: A Review

  2006cites this paper
• Clinical Pharmacology of Sleep

  2006cites this paper
• Drug Class Review on Newer Drugs for Insomnia: Final Report

  2006cites this paper
• Primary insomnia: diagnosis and treatment

  2006cites this paper
• Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.

  2006cites this paper
• Are newer, more expensive pharmacotherapy options associated with superior symptom control compared to less costly agents used in a collaborative practice setting?

  2006cites this paper
• Treating insomnia: Current and investigational pharmacological approaches.

  2006cites this paper
• Zolpidem: a review of its use in the management of insomnia.

  2005cites this paper
• This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the author's clinical recommendations. Chronic Insomnia

  2005cites this paper
• Effects of temazepam 7.5 mg and temazepam 15 mg on sleep maintenance and sleep architecture in a model of transient insomnia

  2005cites this paper
• Current awareness in human psychopharmacology

  2005cites this paper
• Clinical practice. Chronic insomnia.

  2005cites this paper